Genprex, Inc. (NASDAQ:GNPX)

Stock Price: $1.31
+0 (0%)
Updated Dec 2, 2022 09:00 PM GMT+0000
Overview
Financials
Statistics
Profile
Chart
Market Cap 62.91M
Revenue 0
Gross Profit 0
Shares Out 48.02M
EPS (ttm)
PE Ratio 0.0000
Forward PE -2.7872
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Dec 2
Last Price $1.31
Previous Close $1.31
Change ($) 0
Change (%) 0%
Day's Open 1.33
Day's Range 1.3 - 1.34
Day's Volume 60.96K
52 Week Range 1.17 - 3.62

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.

The Company's lead product candidate, REQORSA™ (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (NSCLC). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells.

REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S.

Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca's Tagrisso®) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone.

News

Quick info

Country
United States
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
12
CEO
J. Rodney Varner
Address
1601 Trinity St Bldg B
Austin
Texas
78712-1765
Phone
15125377997
Website
www.genprex.com
Ticker Symbol
GNPX
Reporting Currency
USD